Early Hepatotoxicity of Methotrexate in Rheumatoid Arthritis

Authors

  • M Shakila Parvin Assistant Professor, Department of Pharmacology, Islami Bank Medical College, Rajshahi.
  • Mamun Ur Rashid Professor, Department of Pharmacology, Rajshahi Medical College, Rajshahi.
  • ARM Saifuddin Ekram Professor, Department of Medicine, Rajshahi Medical College, Rajshahi.
  • H Ara Begum Associate Professor, Department of Pharmacology, Rajshahi Medical College, Rajshahi.

DOI:

https://doi.org/10.3329/taj.v21i2.3795

Keywords:

Rheumatoid arthritis

Abstract

The present study was undertaken to evaluate methotrexate induced early hepatotoxicity in rheumatoid arthritis patients. This study was carried out on ARA criteria fulfilling 35 diagnosed rheumatoid arthritis patients of either gender, aged 20-60 years, presented in Medicine Department of Rajshahi Medical College Hospital, Rajshahi from July 2007 to June 2008. Patients with normal liver function tests and HBsAg and anti-HCV negative cases were given oral Methotrexate (10-25mg/week) for 3 months. Baseline level of SGPT, serum bilirubin and prothrombin time was 10.07±0.32u/l, 0.59±0.03mg/dl and 12.97±0.34 seconds respectively. After 3 months of methotrexate therapy, level of SGPT, serum bilirubin and prothrombin time was found to be 12.60±1.16 u/l, 0.70±0.06mg/dl and 13.87±0.45 seconds respectively. During methotrexate therapy SGPT level changed significantly (p<0.05). Change of serum bilirubin and prothrombin time was not significant.

doi: 10.3329/taj.v21i2.3795

TAJ 2008; 21(2): 147-151

Downloads

Download data is not yet available.
Abstract
104
PDF
137

Downloads

How to Cite

Parvin, M. S., Rashid, M. U., Ekram, A. S., & Begum, H. A. (2009). Early Hepatotoxicity of Methotrexate in Rheumatoid Arthritis. TAJ: Journal of Teachers Association, 21(2), 147–151. https://doi.org/10.3329/taj.v21i2.3795

Issue

Vol. 21 No. 2 (2008)

Section

Original Articles